Research Progress on the Role of Hydrogen Sulfide in the Pathological Process of Diabetic Retinopathy
DOI:
https://doi.org/10.54097/c3mp6y70Keywords:
Hydrogen Sulfide (H₂S), Diabetic Retinopathy (DR), Oxidative Stress (OS), Inflammation, HomocysteineAbstract
As a gaseous signaling molecule, hydrogen sulfide (H₂S) plays a role in regulating organ development and sustaining tissue homeostasis. However, overexposure to this compound can lead to harmful effects, triggering cell toxicity, orchestrating pathological mechanisms, and raising the likelihood of multiple disorders. However, when present in appropriate amounts, this gasotransmitter is known to exert beneficial effects on biological systems. Recent research has shed light on the multifaceted effects of hydrogen sulfide, highlighting its ability to counteract oxidative stress, reduce inflammatory responses, and protect retinal tissues from structural and functional impairment. The application of slow-releasing H₂S-providing substances has shown potential as a therapeutic approach for various illnesses, This piece of research summarizes the biological roles played by the metabolism of hydrogen sulfide and explores its potential in treating eye-related conditions.
Downloads
References
[1] ASCHNER P, KARURANGA S, JAMES S, et al. The International Diabetes Federation’s guide for diabetes epidemiological studies[J]. Diabetes Research and Clinical Practice, 2021, 172:108630.
[2] SAEEDI P, PETERSOHN I, SALPEA P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition[J]. Diabetes Research and Clinical Practice, 2019, 157:107843.
[3] WU M-Y, YIANG G-T, LAI T-T, et al. The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy[J]. Oxidative Medicine and Cellular Longevity, 2018, 2018(1):3420187.
[4] SABANAYAGAM C, BANU R, CHEE M L, et al. Incidence and progression of diabetic retinopathy: a systematic review[J]. The Lancet Diabetes & Endocrinology, 2019, 7(2):140–149.
[5] ZENG Q, LUO Y, FANG J, et al. Circ_0000615 promotes high glucose-induced human retinal pigment epithelium cell apoptosis, inflammation and oxidative stress via miR-646/YAP1 axis in diabetic retinopathy[J]. European Journal of Ophthalmology, 2021, 32(3):1584–1595.
[6] DILEK N, PAPAPETROPOULOS A, TOLIVER-KINSKY T, et al. Hydrogen sulfide: An endogenous regulator of the immune system[J]. Pharmacological Research, 2020, 161: 105 119.
[7] PELELI M, ZAMPAS P, PAPAPETROPOULOS A. Hydrogen Sulfide and the Kidney: Physiological Roles, Contribution to Pathophysiology, and Therapeutic Potential[J]. Antioxidants & Redox Signaling, 2021, 36(4-6):220–243.
[8] KIMURA H. Hydrogen Sulfide (H2S) and Polysulfide (H2Sn) Signaling: The First 25 Years[J]. Biomolecules, 2021, 11(6):896.
[9] LV B, CHEN S, TANG C, et al. Hydrogen sulfide and vascular regulation – An update[J]. Journal of Advanced Research, 2021, 27:85–97.
[10] SHI X, LI H, GUO F, et al. Novel ray of hope for diabetic wound healing: Hydrogen sulfide and its releasing agents[J]. Journal of Advanced Research, 2024, 58:105–115.
[11] ZHAO H, LIU H, YANG Y, et al. The Role of H2S Regulating NLRP3 Inflammasome in Diabetes[J]. International Journal of Molecular Sciences, 2022, 23(9):4818.
[12] WANG H, SHI X, QIU M, et al. Hydrogen Sulfide Plays an Important Protective Role through Influencing Endoplasmic Reticulum Stress in Diseases[J]. International Journal of Biological Sciences, 2020, 16(2):264–271.
[13] BEHERA J, TYAGI S C, TYAGI N. Role of hydrogen sulfide in the musculoskeletal system[J]. Bone, 2019, 124:33–39.
[14] KOLLURU G K, SHACKELFORD R E, SHEN X, et al. Sulfide regulation of cardiovascular function in health and disease[J]. Nature Reviews Cardiology, 2022, 20(2):109–125.
[15] OLAS B. Hydrogen sulfide in hemostasis: Friend or foe?[J]. Chemico-Biological Interactions, 2014, 217:49–56.
[16] OLAS B. Hydrogen sulfide in signaling pathways[J]. Clinica Chimica Acta, 2015, 439:212–218.
[17] LIU J, MESFIN F M, HUNTER C E, et al. Recent Development of the Molecular and Cellular Mechanisms of Hydrogen Sulfide Gasotransmitter[J]. Antioxidants, 2022, 11(9):1788.
[18] ARANDA-RIVERA A K, CRUZ-GREGORIO A, ARANCIBIA-HERNáNDEZ Y L, et al. RONS and Oxidative Stress: An Overview of Basic Concepts[J]. Oxygen, 2022, 2(4):437–478.
[19] ASCHNER M, SKALNY A V, KE T, et al. Hydrogen Sulfide (H2S) Signaling as a Protective Mechanism against Endogenous and Exogenous Neurotoxicants[J]. Current Neuropharmacology, 2022, 20(10):1908–1924.
[20] SCAMMAHORN J J, NGUYEN I T N, BOS E M, et al. Fighting Oxidative Stress with Sulfur: Hydrogen Sulfide in the Renal and Cardiovascular Systems[J]. Antioxidants, 2021, 10(3):373.
[21] XIE Z-Z, LIU Y, BIAN J-S, et al. Hydrogen Sulfide and Cellular Redox Homeostasis[J]. Oxidative Medicine and Cellular Longevity, 2016, 2016(1).
[22] KASAI S, SHIMIZU S, TATARA Y, et al. Regulation of Nrf2 by Mitochondrial Reactive Oxygen Species in Physiology and Pathology[J]. Biomolecules, 2020, 10(2):320.
[23] WANG C, ZHOU J, WANG J, et al. Progress in the mechanism and targeted drug therapy for COPD[J]. Signal Transduction and Targeted Therapy, 2020, 5(1):248.
[24] MAO Z, HUANG Y, ZHANG Z, et al. Pharmacological levels of hydrogen sulfide inhibit oxidative cell injury through regulating the redox state of thioredoxin[J]. Free Radical Biology and Medicine, 2019, 134:190–199.
[25] CALABRESE V, SCUTO M, SALINARO A T, et al. Hydrogen Sulfide and Carnosine: Modulation of Oxidative Stress and Inflammation in Kidney and Brain Axis[J]. Antioxidants, 2020, 9(12):1303.
[26] ZHANG J, SHI C, WANG H, et al. Hydrogen sulfide protects against cell damage through modulation of PI3K/Akt/Nrf2 signaling[J]. The International Journal of Biochemistry & Cell Biology, 2019, 117:105636.
[27] KUMAR A, BHATIA M. Role of Hydrogen Sulfide, Substance P and Adhesion Molecules in Acute Pancreatitis[J]. International Journal of Molecular Sciences, 2021, 22(22):12136.
[28] SUNZINI F, DE STEFANO S, CHIMENTI M S, et al. Hydrogen Sulfide as Potential Regulatory Gasotransmitter in Arthritic Diseases[J]. International Journal of Molecular Sciences, 2020, 21(4):1180.
[29] LI J, TENG X, JIN S, et al. Hydrogen sulfide improves endothelial dysfunction by inhibiting the vicious cycle of NLRP3 inflammasome and oxidative stress in spontaneously hypertensive rats[J]. Journal of Hypertension, 2019, 37(8):1633–1643.
[30] ÉVA SIKURA K, COMBI Z, POTOR L, et al. Hydrogen sulfide inhibits aortic valve calcification in heart via regulating RUNX2 by NF-κB, a link between inflammation and mineralization[J]. Journal of Advanced Research, 2021, 27:165–176.
[31] BECHELLI C, MACABREY D, DEGLISE S, et al. Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease[J]. International Journal of Molecular Sciences, 2023, 24(12):9955.
[32] TAKıR S, SEMIZ A T, UYDEŞ DOĞAN B S. Hydrogen sulfide is synthesized endogenously in both retinal artery and retina mostly via CSE[J]. Experimental Eye Research, 2021, 204:108443.
[33] CORNWELL A, BADIEI A. The role of hydrogen sulfide in the retina[J]. Experimental Eye Research, 2023, 234:109568.
[34] KANG Q, YANG C. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications[J]. Redox Biology, 2020, 37:101799.
[35] ZHANG Z, HUANG Q, ZHAO D, et al. The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications[J]. Frontiers in Endocrinology, 2023, 14:1112363.
[36] LI P, LIU H, SHI X, et al. Hydrogen Sulfide: Novel Endogenous and Exogenous Modulator of Oxidative Stress in Retinal Degeneration Diseases[J]. Molecules, 2021, 26(9): 2411.
[37] SI Y F, WANG J, GUAN J, et al. Treatment with hydrogen sulfide alleviates streptozotocin‐induced diabetic retinopathy in rats[J]. British Journal of Pharmacology, 2013, 169(3):619–631.
[38] HAN Y, SHANG Q, YAO J, et al. Hydrogen sulfide: a gaseous signaling molecule modulates tissue homeostasis: implications in ophthalmic diseases[J]. Cell Death & Disease, 2019, 10(4):293.
[39] WANG P, CHEN F, WANG W, et al. Hydrogen Sulfide Attenuates High Glucose-Induced Human Retinal Pigment Epithelial Cell Inflammation by Inhibiting ROS Formation and NLRP3 Inflammasome Activation[J]. Mediators of Inflammation, 2019, 2019:1–13.
[40] TAWFIK A, MOHAMED R, ELSHERBINY N M, et al. Homocysteine: A Potential Biomarker for Diabetic Retinopathy [J]. Journal of Clinical Medicine, 2019, 8(1):121.
[41] SBODIO J I, SNYDER S H, PAUL B D. Regulators of the transsulfuration pathway[J]. British Journal of Pharmacology, 2018, 176(4):583–593.
[42] KOWLURU R A, MOHAMMAD G, SAHAJPAL N. Faulty homocysteine recycling in diabetic retinopathy[J]. Eye and Vision, 2020, 7(1):4.
[43] YANG Q, HE G-W. Imbalance of Homocysteine and H2S: Significance, Mechanisms, and Therapeutic Promise in Vascular Injury[J]. Oxidative Medicine and Cellular Longevity, 2019, 2019:1–11.
[44] MOHAMMAD G, RADHAKRISHNAN R, KOWLURU R A. Hydrogen Sulfide: A Potential Therapeutic Target in the Development of Diabetic Retinopathy[J]. Investigative Opthalmology & Visual Science, 2020, 61(14):35.
[45] GEORGE A K, HOMME R P, TYAGI D S S C, et al. Protecting the aging eye with hydrogen sulfide[J]. Canadian Journal of Physiology and Pharmacology, 2021–02, 99(2): 161–170.
[46] RAN R, DU L, ZHANG X, et al. ELEVATED HYDROGEN SULFIDE LEVELS IN VITREOUS BODY AND PLASMA IN PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY[J]. Retina, 2014, 34(10):2003–2009.
[47] HAN Y, ZHANG X, ZHOU Z, et al. Hydrogen sulfide serves as a biomarker in the anterior segment of patients with diabetic retinopathy[J]. International Ophthalmology, 2020, 40(4):891–899.
[48] DU J, JIN H, YANG L. Role of Hydrogen Sulfide in Retinal Diseases[J]. Frontiers in Pharmacology, 2017, 8:588.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
